Form 4: Cytosorbents CFO Peter Mariani Acquires 20,000 Shares in Open Market Purchase

Cytosorbents' Chief Financial Officer, Peter Mariani, recently purchased 20,000 shares of the company's common stock on the open market.

Summary

• Peter Mariani, the Chief Financial Officer of Cytosorbents Corp, acquired 20,000 shares of common stock on December 13, 2024.
• The shares were purchased on the open market at a weighted average price of $0.9647 per share.
• The price range for the purchases was between $0.8902 and $1.09 per share.
• Following the transaction, Mariani directly owns 401,363 shares of Cytosorbents common stock.
• This total includes 110,000 restricted stock units (RSUs) that vest upon a change in control or the fourth anniversary of the grant date.
• It also includes 65,000 RSUs that vest in two equal installments on the first and second anniversaries of the grant date.
• Additionally, 175,000 RSUs vest upon a change in control of the company.
• The remaining 51,363 shares are directly owned by Mariani.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the open market purchase by the CFO, indicating confidence. However, it's a single transaction and not a major event.

Positives

• The purchase of shares by the CFO may indicate confidence in the company's future prospects.
• The open market purchase suggests a genuine investment by the CFO, rather than an option exercise or grant.

Industry Context

Insider trading activity is closely monitored by investors as it can provide insights into management's view of the company's prospects. This purchase by the CFO is a positive signal.

Comparison to Industry Standards

• Insider purchases are generally viewed positively by the market, especially when they are open market purchases rather than option exercises.
• Comparing this to other similar biotech companies, insider buying is often seen as a sign of confidence in the company's future performance.
• For example, if a CFO of a company like Incyte or Regeneron were to make a similar open market purchase, it would likely be viewed as a positive signal by investors.

Stakeholder Impact

• The purchase may positively impact shareholder confidence.
• The purchase may have a minor positive impact on the stock price.

Key Dates

Keywords

Cytosorbents, CTSO, Peter Mariani, insider trading, stock purchase, common stock, restricted stock units, RSUs, open market